Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma
Authors:
- 1 February 2017
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 12 (2) , 269-280
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- CYP24A1Is an Independent Prognostic Marker of Survival in Patients with Lung AdenocarcinomaClinical Cancer Research, 2011
- Placenta-specific Methylation of the Vitamin D 24-Hydroxylase GeneJournal of Biological Chemistry, 2009
- Respiratory Epithelial Cells Convert Inactive Vitamin D to Its Active Form: Potential Effects on Host DefenseThe Journal of Immunology, 2008
- Characterizing Early Events Associated with the Activation of Target Genes by 1,25-Dihydroxyvitamin D3 in Mouse Kidney and Intestine in VivoJournal of Biological Chemistry, 2007
- CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancerInternational Journal of Cancer, 2006
- Vitamin DAmerican Journal of Physiology-Renal Physiology, 2005
- Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancerAnnals of Oncology, 2004
- Vitamin DAmerican Journal of Physiology-Renal Physiology, 1999
- Mouse Vitamin D-24-Hydroxylase: Molecular Cloning, Tissue Distribution, and Transcriptional Regulation by 1α,25-Dihydroxyvitamin D3*Endocrinology, 1997
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970